Drug Detail:Tenapanor (Tenapanor [ ten-a-pa-nor ])
Drug Class: NHE3 inhibitors
Tenapanor Levels and Effects while Breastfeeding
Summary of Use during Lactation
No information is available on the clinical use of tenapanor during breastfeeding. However, it is minimally absorbed orally and 99% bound to plasma proteins, so the amount in milk is likely to be negligible and would not be significantly absorbed by the infant. If tenapanor is required by the mother, it is not a reason to discontinue breastfeeding.
Drug Levels
Maternal Levels. Relevant published information was not found as of the revision date.
Infant Levels. Relevant published information was not found as of the revision date.
Effects in Breastfed Infants
Relevant published information was not found as of the revision date.
Effects on Lactation and Breastmilk
Relevant published information was not found as of the revision date.
Alternate Drugs to Consider
(Irritable Bowel Syndrome) Linaclotide, Lubiprostone, Plecanatide, Polyethylene Glycol, Psyllium
Substance Identification
Substance Name
Tenapanor
CAS Registry Number
1234423-95-0
Drug Class
Breast Feeding
Lactation
Gastrointestinal Agents
Membrane Transport Modulators
Laxatives
-
Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. The U.S. government does not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.
- Drug Levels and Effects
- Substance Identification